Shanghai MicuRx Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Shanghai MicuRx Pharmaceutical has a total shareholder equity of CN¥654.6M and total debt of CN¥182.1M, which brings its debt-to-equity ratio to 27.8%. Its total assets and total liabilities are CN¥1.0B and CN¥348.2M respectively.
Key information
27.8%
Debt to equity ratio
CN¥182.11m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥776.89m |
| Equity | CN¥654.63m |
| Total liabilities | CN¥348.22m |
| Total assets | CN¥1.00b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688373's short term assets (CN¥896.4M) exceed its short term liabilities (CN¥108.4M).
Long Term Liabilities: 688373's short term assets (CN¥896.4M) exceed its long term liabilities (CN¥239.8M).
Debt to Equity History and Analysis
Debt Level: 688373 has more cash than its total debt.
Reducing Debt: 688373 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 688373 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 688373 has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 21.1% each year.